Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

Money

Could China’s COVID vaccine save the world?

Published

on

Most scientists are of the view that coronavirus originated from China, after all Wuhan was ground zero for the pandemic which began early last year.

Since then, millions have died and many more have been infected. Our way of life has been turned upside down.

Now the World Health organisation has granted emergency approval for China’s COVID vaccine – which is made by Chinese state-owned company Sinopharm.

It is the first vaccine developed by a non-Western country to get WHO backing. And it’s big news, especially for developing nations.

The vaccine has already been given to millions of people in China and elsewhere. 

Already, health regulators in various countries – especially poorer ones in Africa, Latin America and Asia – have approved Chinese jabs for emergency use.

The effectiveness of the various Chinese vaccines has long been uncertain.

WHO says the addition of the vaccine had “the potential to rapidly accelerate Covid-19 vaccine access for countries seeking to protect health workers and populations at risk”.

It is recommending that the vaccine be administered in two doses, especially to those aged 18 and over.

https://twitter.com/WHO/status/1390704054267961346?s=20

Does it even matter?

The green light from the global health body is a guideline for national regulators that a vaccine is safe and effective. 

WHO director-general Tedros Adhanom Ghebreyesus said it would give countries “confidence to expedite their own regulatory approval”.

In addition to China, countries already using the vaccine include the UAE, Pakistan and Hungary. 

The decision on Friday to approve the vaccine for emergency use was made by the WHO’s technical advisory group, which reviewed the latest clinical data and manufacturing practices. 

It said the vaccine’s efficacy for symptomatic and hospitalised cases of Covid-19 was estimated to be 79%.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Money

Why the meme-stock frenzy is unlikely to repeat

Published

on

GME shares surge 74%, but experts stress a meme-stock frenzy resurgence is unlikely due to fundamental differences in the company’s financial situation.

Australia’s budget unveils a second consecutive surplus of A$9.3 billion, prioritising the critical minerals industry and green energy initiatives to reduce reliance on Chinese supply.

Also, GameStop shares have surged 74%, but experts caution against expecting a repeat of the 2021 meme-stock frenzy. #featured #trending

Continue Reading

Money

Why are airlines after the Biden Administration?

Published

on

Major airlines are taking legal action against the Biden administration over a newly implemented rule requiring them to disclose fees upfront.

On this episode of Hot Shots – Major airlines are suing the Biden Administration, AI-piloted fighter jets, SpaceX faces funding challenges, and Apple receives crushing feedback.

Ticker’s Ahron Young & Veronica Dudo discuss. #featured #trending

Continue Reading

Money

The mounting pressure on Government spends

Published

on

Questions abound regarding the factors fueling this inflation surge in Australia and whether it correlates with the escalating government expenditures.

Concerns extend to how Chalmers navigates the mounting pressure amid discrepancies in spending allocations.

Moreover, as Australians grapple with the reality of rising living costs, the feasibility of cutting spending becomes a pressing issue. Additionally, amidst economic uncertainties, individuals seek guidance on managing stock market risks effectively. #Featured #Trending

Continue Reading

Trending Now